12.48
price up icon3.06%   0.37
after-market 시간 외 거래: 12.47 -0.010 -0.08%
loading
전일 마감가:
$12.11
열려 있는:
$12.18
하루 거래량:
309.64K
Relative Volume:
0.67
시가총액:
$1.69B
수익:
$7.50M
순이익/손실:
$-81.89M
주가수익비율:
0.2354
EPS:
53.0176
순현금흐름:
$-63.58M
1주 성능:
-13.27%
1개월 성능:
-27.23%
6개월 성능:
+52.75%
1년 성능:
+149.10%
1일 변동 폭
Value
$11.88
$12.58
1주일 범위
Value
$11.88
$14.29
52주 변동 폭
Value
$4.60
$22.00

Mesoblast Ltd Adr Stock (MESO) Company Profile

Name
명칭
Mesoblast Ltd Adr
Name
전화
-
Name
주소
-
Name
직원
0
Name
트위터
@Mesoblast
Name
다음 수익 날짜
2025-02-24
Name
최신 SEC 제출 서류
Name
MESO's Discussions on Twitter

MESO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
MESO
Mesoblast Ltd Adr
12.48 1.69B 7.50M -81.89M -63.58M 53.02
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
484.82 131.41B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
634.23 72.26B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
591.87 36.10B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
270.02 35.03B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
272.17 28.24B 3.81B -644.79M -669.77M -6.24

Mesoblast Ltd Adr Stock (MESO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-12-23 다운그레이드 Jefferies Buy → Hold
2024-09-24 업그레이드 Maxim Group Hold → Buy
2024-08-29 업그레이드 Jefferies Hold → Buy
2024-07-23 업그레이드 Piper Sandler Neutral → Overweight
2023-08-31 업그레이드 Jefferies Hold → Buy
2023-08-07 다운그레이드 Maxim Group Buy → Hold
2023-08-04 다운그레이드 Piper Sandler Overweight → Neutral
2023-08-04 다운그레이드 William Blair Outperform → Mkt Perform
2023-03-09 개시 William Blair Outperform
2022-12-06 다운그레이드 Jefferies Buy → Hold
2022-09-06 개시 Piper Sandler Overweight
2021-04-07 업그레이드 Maxim Group Hold → Buy
2020-12-22 다운그레이드 Maxim Group Buy → Hold
2020-12-04 다운그레이드 Chardan Capital Markets Neutral → Sell
2020-10-22 개시 RBC Capital Mkts Sector Perform
2020-08-14 재확인 Maxim Group Buy
2020-05-28 재확인 H.C. Wainwright Buy
2019-01-31 재개 H.C. Wainwright Buy
2018-03-22 다운그레이드 Credit Suisse Neutral → Underperform
2018-02-28 재확인 Cantor Fitzgerald Buy
2017-08-31 개시 Oppenheimer Outperform
2017-06-08 개시 Cantor Fitzgerald Buy
모두보기

Mesoblast Ltd Adr 주식(MESO)의 최신 뉴스

pulisher
Mar 30, 2025

Mesoblast (ASX:MSB) Secures Medicaid Agreement for Ryoncil® - thecapitalclub.com.au

Mar 30, 2025
pulisher
Mar 30, 2025

First Three Children to Commence Treatment With Ryoncil® - GlobeNewswire Inc.

Mar 30, 2025
pulisher
Mar 20, 2025

UPDATED: Your guide to February Reporting Season 2020 - Morningstar.com.au

Mar 20, 2025
pulisher
Mar 03, 2025

21 Best-Performing Small-Cap Stocks for March 2025 - NerdWallet

Mar 03, 2025
pulisher
Feb 09, 2025

Why Mesoblast Ltd ADR (NASDAQ: MESO) Is Worth Including On Your Watchlist - Marketing Sentinel

Feb 09, 2025
pulisher
Feb 06, 2025

The 98.76% Simple Moving Average of Mesoblast Ltd ADR’s (MESO) Stock in the Past 200 Days - The News Heater

Feb 06, 2025
pulisher
Feb 01, 2025

Mesoblast Ltd ADR (NASDAQ:MESO) Shares Are Up 10.24 Percent In A Week – But Can The Gains Continue? - Marketing Sentinel

Feb 01, 2025
pulisher
Jan 10, 2025

Why are Mesoblast shares in a trading halt? - The Motley Fool Australia

Jan 10, 2025
pulisher
Jan 09, 2025

Mesoblast Limited Initiates Trading Halt Pending Financing Announcement - TipRanks

Jan 09, 2025
pulisher
Jan 08, 2025

ASX December health sector winners… and a 91pc drop for a trial-flopped stock - Stockhead

Jan 08, 2025
pulisher
Jan 03, 2025

MESO Stock Surges 80% In A Month After FDA Approval Of GVHD Drug - Barchart

Jan 03, 2025
pulisher
Jan 02, 2025

Mesoblast (NASDAQ:MESO) Shares Gap UpWhat's Next? - MarketBeat

Jan 02, 2025
pulisher
Dec 31, 2024

ASX healthcare 2024 winners and losers, plus what’s next for 2025 - Stockhead

Dec 31, 2024
pulisher
Dec 30, 2024

Investors: What’s The Real Deal With W & T Offshore Inc (NYSE: WTI) - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

What Analysts Think About TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP)’s Potential Raise - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

No Stopping Argo Blockchain Plc ADR (NASDAQ: ARBK)’s Stock Plunged? - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

NIO Inc ADR (NYSE: NIO) Stock Forecast: Could Pass $8 In A Year - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

If You Don’t Buy Safe Pro Group Inc (NASDAQ: SPAI) Now, You’ll Regret It Later - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

What Do Analysts Think About Aspen Aerogels Inc’s (NYSE:ASPN) Future? - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

Would I Buy Opendoor Technologies Inc (NASDAQ: OPEN) Stock At Any Time In The Future? - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

Tempest Therapeutics Inc (NASDAQ: TPST) Investors Should Be Worried About This. - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

Cytek Biosciences, Emergent BioSolutions, Radiopharm Theranostics And Other Big Stocks Moving Higher On Monday - Benzinga

Dec 30, 2024
pulisher
Dec 30, 2024

Petco Health and Wellness Co Inc (NASDAQ: WOOF): A Hidden Gem Despite Volatility - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

Where Do Analysts See Gamestop Corporation (NYSE: GME) Heading? - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

Mesoblast Stock Soars to 52-Week High, Hits $19.15 - Investing.com

Dec 30, 2024
pulisher
Dec 30, 2024

Here’s Why Lineage Cell Therapeutics Inc (AMEX: LCTX) Is An Attractive Investment Right Now - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

No Stopping Editas Medicine Inc (NASDAQ: EDIT)’s Stock Plunged? - Stocks Register

Dec 30, 2024
pulisher
Dec 30, 2024

What Do Analysts Think About Therealreal Inc’s (NASDAQ:REAL) Future? - Stocks Register

Dec 30, 2024
pulisher
Dec 26, 2024

What Awaits These 4 Biotech Stocks That More Than Doubled In 2024 - Barchart

Dec 26, 2024
pulisher
Dec 23, 2024

Mesoblast shares downgraded to hold by Jefferies By Investing.com - Investing.com South Africa

Dec 23, 2024
pulisher
Dec 20, 2024

Why the Mesoblast share price is diving 18% after an FDA win - The Motley Fool Australia

Dec 20, 2024
pulisher
Dec 19, 2024

Mesoblast share price rockets 30% on big US FDA news - The Motley Fool Australia

Dec 19, 2024
pulisher
Dec 16, 2024

Mesoblast stock soars to 52-week high, hits $12.21 - Investing.com

Dec 16, 2024
pulisher
Dec 03, 2024

Mesoblast Stock Soars to 52-Week High, Hits $12.19 - Investing.com

Dec 03, 2024
pulisher
Nov 26, 2024

Best Momentum Stocks to Buy for November 26th - Yahoo Finance

Nov 26, 2024
pulisher
Nov 21, 2024

Investors Heavily Search Sea Limited Sponsored ADR (SE): Here is What You Need to Know - Yahoo Finance

Nov 21, 2024
pulisher
Nov 13, 2024

Mesoblast stock soars to 52-week high, hits $11.1 - Investing.com

Nov 13, 2024
pulisher
Oct 18, 2024

Mesoblast files annual report and meeting notice - Investing.com India

Oct 18, 2024
pulisher
Oct 08, 2024

JPMorgan Takes Substantial Stake in Mesoblast Ltd - TipRanks

Oct 08, 2024
pulisher
Oct 02, 2024

Mesoblast stock soars to 52-week high, hits $8.7 - Investing.com

Oct 02, 2024
pulisher
Sep 30, 2024

Mesoblast: Undervalued Due To Remestemcel-L's Substantial Growth Potential (NASDAQ:MESO) - Seeking Alpha

Sep 30, 2024
pulisher
Sep 24, 2024

What Makes Holcim Ltd Unsponsored ADR (HCMLY) a Strong Momentum Stock: Buy Now? - Yahoo Finance

Sep 24, 2024
pulisher
Aug 29, 2024

Mesoblast stock gains momentum ahead of 2025 PDUFA dateJefferies - Investing.com

Aug 29, 2024
pulisher
Jul 23, 2024

Australia stocks higher at close of trade; S&P/ASX 200 up 0.50% - Investing.com

Jul 23, 2024
pulisher
Jul 22, 2024

Mesoblast: Rolling The Dice On Cellular Medicines (NASDAQ:MESO) - Seeking Alpha

Jul 22, 2024
pulisher
Apr 26, 2024

Check Up: Big breakthrough in acne treatment, and recent ASX biotech winners - Stockhead

Apr 26, 2024
pulisher
Apr 01, 2024

Australia stocks higher at close of trade; S&P/ASX 200 up 0.99% - Investing.com

Apr 01, 2024
pulisher
Mar 24, 2024

11 Best ASX Stocks To Buy Now - Yahoo Finance

Mar 24, 2024
pulisher
Feb 28, 2024

Sea Limited (SE) to Report Q4 Earnings: What's in Store? - Yahoo Finance

Feb 28, 2024
pulisher
Feb 12, 2024

symbol__ Stock Quote Price and Forecast - CNN

Feb 12, 2024
pulisher
Feb 05, 2024

10 Best Australian Stocks To Buy - Yahoo Finance

Feb 05, 2024

Mesoblast Ltd Adr (MESO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$70.69
price down icon 1.05%
$76.29
price down icon 2.18%
$31.13
price down icon 0.77%
$19.29
price down icon 5.07%
$91.06
price down icon 4.10%
biotechnology ONC
$272.17
price up icon 1.79%
자본화:     |  볼륨(24시간):